Access Statistics for Dana P. Goldman

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Economic Evaluation of the War on Cancer 0 0 1 95 0 2 17 340
Are the Young Becoming More Disabled? 0 0 0 93 0 0 2 339
Can Patient Self-Management Help Explain the SES Health Gradient? 0 0 0 160 2 2 15 601
Criminal Prosecution and HIV-related Risky Behavior 0 0 0 27 1 1 4 243
Disentangling Moral Hazard and Adverse Selection in Private Health Insurance 0 0 5 40 3 7 29 76
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 84 84 4 5 20 20
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 21 21 1 2 22 22
Employee Responses to Health Insurance Premium Increases 0 1 1 23 1 2 6 167
Food Prices and the Dynamics of Body Weight 0 0 0 66 2 2 13 211
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 0 7 619
Health Care Spending: Historical Trends and New Directions 0 0 0 40 1 2 7 67
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 50 2 3 8 180
Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician 0 0 0 2 0 1 7 36
Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand 2 3 5 115 8 10 27 396
How Costly Is Hospital Quality? A Revealed-Preference Approach 0 0 1 90 2 5 11 294
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 0 0 6 79 4 6 29 99
Integrated Insurance Design in the Presence of Multiple Medical Technologies 0 0 1 21 0 0 5 160
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 34 2 2 12 119
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 3 3 12 242
International Differences in Longevity and Health and their Economic Consequences 0 0 0 54 3 3 10 163
Market Evidence of Misperceived Prices and Mistaken Mortality Risks 0 0 0 51 1 1 4 289
Medical Expenditure Risk and Household Portfolio Choice 0 0 0 75 2 3 8 310
Medical Expenditure Risk and Household Portfolio Choice 0 0 3 3 1 2 12 22
Moral Hazard and Adverse Selection in Private Health Insurance 0 2 7 13 0 8 25 41
Prescription Drug Coverage and Elderly Medicare Spending 0 0 0 49 0 0 6 335
Price Variation in Markets with Homogeneous Goods The Case of Medigap 0 0 0 0 1 1 7 14
Price Variation in Markets with Homogeneous Goods: The Case of Medigap 0 0 0 41 2 5 11 225
Socioeconomic Differences in the Adoption of New Medical Technologies 0 0 0 65 1 1 2 262
Terminal Care and The Value of Life Near Its End 0 4 8 183 7 16 43 603
The Effects of Product Liability Exemption in the Presence of the FDA 0 0 1 19 3 3 13 189
The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006 0 0 0 77 2 4 16 189
The Effects of Relative Food Prices on Obesity – Evidence from China: 1991-2006 0 0 0 30 1 2 12 132
The Link Between Public and Private Insurance and HIV-Related Mortality 0 0 0 79 1 2 6 475
The Reallocation of Compensation in Response to Health Insurance Premium Increases 0 0 0 52 3 5 9 330
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 1 28 1 3 12 151
Understanding Health Disparities Across Education Groups 0 1 1 390 2 4 14 1,656
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 1 42 4 4 13 216
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 2 36 2 4 9 108
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 1 49 4 4 15 173
Wage and Benefit Changes in Response to Rising Health Insurance Costs 0 0 0 54 1 1 6 287
Total Working Papers 2 11 150 2,565 78 131 506 10,401


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Reexamination of the Costs of Medical R&D Regulation 1 1 3 10 2 4 10 45
A Theory of Health Disparities and Medical Technology 0 2 10 113 1 7 32 461
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 15 0 2 4 97
An economic evaluation of the war on cancer 0 0 3 101 2 3 32 494
Are Biopharmaceutical Budget Caps Good Public Policy? 1 2 6 12 4 8 19 43
Can patient self-management explain the health gradient? revisited: A response to Maitra 0 0 0 11 1 1 3 32
Can the ACA Improve Population Health? 0 0 0 13 1 3 5 57
Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior 0 0 0 8 1 3 13 85
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 25 1 1 7 92
Digesting the doughnut hole 0 0 2 5 1 1 11 47
Disability Forecasts and Future Medicare Costs 1 1 1 33 4 5 9 254
Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? 0 0 1 2 2 3 19 42
Do Statins Reduce the Health and Health Care Costs of Obesity? 0 0 0 5 0 0 5 23
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 1 1 1 1 3 6 6 6
Does age or life expectancy better predict health care expenditures? 0 0 1 86 1 1 8 286
Effect of Insurance on Mortality in an HIV-Positive Population in Care 0 0 0 11 1 2 5 79
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 1 1 2 20
Estimated prevalence of undiagnosed atrial fibrillation in the United States 0 0 0 0 0 1 1 1
Geographic Variation in Health Care: The Role of Private Markets 0 2 6 66 2 14 40 310
Geographic variation in the delivery of high-value inpatient care 0 0 0 0 0 0 0 0
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 1 2 3 20
HIV Breakthroughs and Risky Sexual Behavior 0 1 2 157 3 5 16 873
Health Care Spending: Historical Trends and New Directions 0 0 0 4 3 7 16 59
Health and Health Care of Medicare Beneficiaries in 2030 0 0 0 8 1 2 13 49
How Costly is Hospital Quality? A Revealed‐Preference Approach 0 0 1 7 1 1 5 58
How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms 1 5 7 31 4 11 43 171
IT IS TIME FOR UNIVERSAL COVERAGE WITHOUT BREAKING THE BANK 0 1 1 2 0 1 5 8
Integrated Insurance Design in the Presence of Multiple Medical Technologies 0 0 0 20 3 4 12 219
MEDICAL EXPENDITURE RISK AND HOUSEHOLD PORTFOLIO CHOICE 0 0 0 0 3 4 16 111
MEDICARE†FOR†ALL: NOT OUR ONLY OPTION FOR UNIVERSAL COVERAGE 0 0 0 0 0 1 5 8
Managed Care as a Public Cost-Containment Mechanism 0 0 1 48 1 1 5 515
Market evidence of misperceived mortality risk 0 0 0 9 1 1 2 30
Medical Expenditure Measures in the Health and Retirement Study 0 0 0 34 1 2 3 117
Part D Formulary and Benefit Design as a Risk-Steering Mechanism 0 0 0 26 1 1 4 123
Patient Cost-Sharing and Healthcare Spending Growth 0 0 3 62 1 2 17 237
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 2 40 1 4 12 156
Prescription Drug Coverage and Medicare Spending among U.S. Elderly&ast 0 0 0 16 0 0 3 77
Price Regulation in Secondary Insurance Markets 0 0 0 9 0 0 4 73
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 7 33 4 5 32 121
Queuing for Surgery: Is the U.S. or Canada Worse Off? 0 0 1 146 1 1 2 1,101
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 1 1 1 1 5 15
Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards 0 0 0 2 1 1 4 42
Racial and ethnic disparities in medication adherence among privately insured patients in the United States 0 0 0 0 0 0 1 1
Socioeconomic Differences in the Adoption of New Medical Technologies 0 0 0 32 0 0 9 211
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 6 64 5 7 30 261
The Costs of A Medicare Prescription Drug Benefit 0 0 0 60 0 2 5 650
The Fiscal Consequences of Trends in Population Health 0 0 1 12 1 2 11 48
The Future of US Health Care: Is Medicare Really Better at “Saving” Money? 0 0 1 29 0 1 6 88
The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare 0 0 0 37 1 1 10 153
The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older 0 0 0 0 0 0 0 0
The Value of Diagnostic Testing in Personalized Medicine 0 0 4 51 3 9 27 191
The Value of Elderly Disease Prevention 0 0 0 115 2 5 9 430
The association between observed mobility and quality of life in the near elderly 0 0 0 0 0 0 0 0
The benefits of risk factor prevention in Americans aged 51 years and older 0 0 0 0 1 1 4 4
The effects of benefit design and managed care on health care costs 0 0 0 26 0 0 2 90
The increasing value of education to health 0 0 2 18 1 3 11 73
The link between public and private insurance and HIV-related mortality 0 0 0 31 1 1 8 282
The long-term impact of functional disability on hospitalization spending in Singapore 0 0 2 2 0 3 7 7
The potential impact of comparative effectiveness research on U.S. Health Care expenditures 0 0 0 0 1 1 5 14
The reallocation of compensation in response to health insurance premium increases 0 0 0 12 1 4 15 146
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 12 1 2 9 83
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 25 1 1 5 95
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 1 21 1 2 9 117
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 2 55 0 1 5 285
Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000 0 0 0 8 1 1 6 78
Total Journal Articles 5 16 79 1,787 81 170 652 9,964


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Economic Dimensions of Personalized and Precision Medicine 0 0 0 0 2 4 24 25
Frontiers in Health Policy Research, Volume 10 0 0 0 0 1 1 4 31
Frontiers in Health Policy Research, volume 12 0 0 0 0 2 4 9 53
Frontiers in Health Policy Research, volume 13 0 0 0 0 2 2 10 55
Total Books 0 0 0 0 7 11 47 164


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis 0 0 0 18 2 2 4 69
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 0 0 0 8 26
Disability Forecasts and Future Medicare Costs 0 0 0 21 3 3 8 96
Disability and Spending Growth 0 0 0 5 1 1 4 27
Food Prices and the Dynamics of Body Weight 0 0 0 12 1 1 3 59
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 0 0 7 73 3 9 37 181
Introduction to "Economic Dimensions of Personalized and Precision Medicine" 1 3 11 20 2 4 30 71
Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 0 2 2 11 13
The Effects of Product Liability Exemption in the Presence of the FDA 0 0 1 19 2 4 19 78
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 0 2 2 4 35
Total Chapters 1 3 19 168 18 28 128 655


Statistics updated 2020-09-04